Article
Decoding molecular programs in melanoma brain metastases.
Nature communications - 26 Nov 2022
Radke Josefine, Schumann Elisa, Onken Julia, Koll Randi, Acker Güliz, Bodnar Bohdan, Senger Carolin, Tierling Sascha, Möbs Markus, Vajkoczy Peter, Vidal Anna, Högler Sandra, Kodajova Petra, Westphal Dana, Meier Friedegund, Heppner Frank, Kreuzer-Redmer Susanne, Grebien Florian, Jürchott Karsten, Redmer Torben
Abstract excerpt
Melanoma brain metastases (MBM) variably respond to therapeutic interventions; thus determining patient's prognosis. However, the mechanisms that govern therapy response are poorly understood. Here, we use a multi-OMICS approach and targeted sequencing (TargetSeq) to unravel the programs that potentially control the development of progressive intracranial disease. Molecularly, the expression of E-cadherin (Ecad)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
